Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1/2 1

Status

Completed 2Terminated 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 3Classical hematology 3Lymphoid 2Myeloid 1CNS 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 52Leukemia, Myeloid, Acute 51Myelodysplastic Syndromes 45Leukemia 34Lymphoma, Non-Hodgkin 33Lymphoma 28Leukemia, Myelogenous, Chronic, BCR-ABL Positive 24Hematologic Neoplasms 20Breast Neoplasms 19Hodgkin Disease 18Leukemia, Lymphocytic, Chronic, B-Cell 16Burkitt Lymphoma 15Multiple Myeloma 13Neuroblastoma 12Lymphoma, Large B-Cell, Diffuse 12Leukemia, Myeloid, Accelerated Phase 12Leukemia, Biphenotypic, Acute 11Central Nervous System Neoplasms 11Blast Crisis 11Lymphoma, Large-Cell, Immunoblastic 10Lymphoma, Follicular 10Graft vs Host Disease 10Dendritic Cell Sarcoma, Interdigitating 10Anemia, Refractory, with Excess of Blasts 10Recurrence 9Myeloproliferative Disorders 9Medulloblastoma 9Lymphoma, Mantle-Cell 9Leukemia, Myeloid, Chronic-Phase 9Congenital Abnormalities 9

Interventions

fludarabine phosphate 5fludarabine 4Whole-Body Irradiation 4Melphalan 4Cyclophosphamide 4Thiotepa 3Busulfan 3Alemtuzumab 3Therapeutics 2Blood Specimen Collection 2Antilymphocyte Serum 2thymoglobulin 1fosphenytoin 1Photopheresis 1Phenytoin 1Peripheral Blood Stem Cell Transplantation 1Mycophenolic Acid 1Mesna 1Injections 1Influenza Vaccines 1Honey 1Holistic Health 1Exercise 1Cyclosporins 1Cyclosporine 1Clofarabine 1Clinical Trials, Phase I as Topic 1Cell Count 1Bone Marrow Transplantation 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Immunologic Deficiency Syndromes × Thiotepa × Clear all
NCT03609840 2023-09-21

Study of Thiotepa and TEPA Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients

University of California, San Francisco

Completed
25 enrolled
Classical hematologyOther hematologic neoplasm

Anemia, Sickle Cell, Fanconi Anemia, Hemoglobinopathies, Immunologic Deficiency Syndromes, Thalassemia, Hematologic Neoplasms

NCT00801931 2019-03-27

Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders

Columbia University

Phase 1/2 Terminated
1 enrolled 8 charts
CNSClassical hematologyLymphoidOther hematologic neoplasm

Anemia, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Neuroblastoma

NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡